Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers

NCT03375957 is registered in ClinicalTrials.gov with UNION therapeutics as lead sponsor.

NCT NCT03375957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers
Lead sponsor
UNION therapeutics
Phase
Phase 1
Overall status
Completed
Start date
January 8, 2018
Completion date
March 15, 2018
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sensitivity, contact